Navigation Links
Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results

and general and administrative expenses of $2.7 million compared to $5.5 million and $4.1 million respectively, in the period ending March 31, 2007. Other income for the first quarter of 2008 was $2.5 million, compared to other income of $3.2 million in the first quarter of 2007.

Cash, cash equivalents, and investments as of March 31, 2008 were $9.9 million compared to $13.9 million at March 31, 2007.

The Company anticipates that its existing capital resources are sufficient to enable it to continue operations through August 2008. "Emisphere continues to implement aggressive cost controls to conserve our cash," said Michael V. Novinski, President and Chief Executive Officer. "We believe that by mid-year we will be able to announce partnerships that will enable us to fund the company for some time going forward."


Emisphere recently announced that preclinical studies using dogs further demonstrate that its proprietary eligen(R) technology enhances the absorption of oral B12. These data confirm in a second animal species Emisphere's earlier reported proof of concept studies conducted in rats.

"These additional studies are an important milestone in our plans to commercialize our eligen(R) technology," said Novinski. "Most importantly, the data is useful to us as we move forward with clinical human trials, which should begin in June 2008. A safe, effective, and better-absorbed oral formulation of vitamin B12 will enable us to move towards commercial success and, ultimately, profits."

There are at least five million people in the United States receiving 40 million B12 injections annually to treat a variety of debilitating medical conditions, and over 600 million tablets of B12 of various strengths are sold in the United States annually. The company believes that 40 million injections suggests a need for an oral B12 preparation that can deliver therapeutic levels of B12, and that the megadoses be

SOURCE Emisphere Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results
2. Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
3. Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008
4. Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results
5. Emisphere Technologies, Inc. Announces Conference Call for 2007 Fourth Quarter and Year End Financial Results
6. Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12
7. Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
8. Emisphere to Host Business Strategy Conference Call on February 7
9. Emisphere Technologies, Inc. Moves Into New Corporate Headquarters
10. Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
11. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
Post Your Comments:
(Date:10/8/2015)... 8, 2015   Intrexon Corporation (NYSE: ... the appointment of Joseph L. Vaillancourt as ... Nir Nimrodi who continues in his role as ... endeavors to generate sustainable, biologically based solutions to environmental ... he held a variety of key roles including, Vice ...
(Date:10/8/2015)... WAYNE, Pa. , Oct. 8, 2015  Clarkston ... announced the call for applications for the 2016 Clarkston ... in a life sciences related field of study, a ... the selected Clarkston Scholar will receive exposure to the ... participation in Pennsylvania Bio events over the course of ...
(Date:10/8/2015)... RICHARDSON, Texas , Oct. 8, 2015 The 2015 ... graduate of The University of Texas at Dallas. Aziz ... from UT Dallas in 1977, is one ... detailing how cells continuously monitor and repair damaged DNA on a ... PhD in molecular and cell biology from UT Dallas ...
(Date:10/8/2015)... Oct. 8, 2015  Today the Wyss Institute for ... of its start-up company Opsonix Inc. The ... Harvard,s Office of Technology Development (OTD) and Opsonix ... therapy for clinical use. --> ... a million people every year in the U.S. — ...
Breaking Biology Technology:
... new study shows that the availability of hydrogen plays ... makeup of graphene oxide, a material that has potential ... and energy storage. The study also found ... chemical properties continue to evolve for more than a ...
... Hill Community College (BHCC) celebrated the graduation of ... (CBCP) in a ceremony that also marked the ... collaborative effort between BHCC,s Workforce Development Center, the ... targets low-income Cambridge residents who complete – at ...
... Technologies (DTT) is pleased to announce the first sale ... Pediatric Dental Group PC.   "We,re excited to add ditto ... it in our office and had spectacular results," states ... ditto™ dental is a clinical tool developed ...
Cached Biology Technology:
(Date:9/10/2015)... 2015 Report Details The global ... upon previous expectations of revenues, consumer adoption and even ... in which wearables begin to achieve that mass market ... main reasons is the entrance of Apple to the ... market, but the overall size of the wearable technology ...
(Date:9/9/2015)... , Sept. 9, 2015  NuData Security announced ... solution-based milestones, furthering the company,s commitment to protecting ... fraud. NuData Security,s online fraud detection ... company,s growth cycle. The product combines continual analysis ... good user behavior from fraudulent behavior, allowing the ...
(Date:9/2/2015)... -- About hand geometry biometrics Security has been ... and hospitals as well as for individuals to secure ... are used to prevent unauthorised access. Hand geometry biometrics ... an individual, width of the fingers, and thickness of ... reflectors can be used for capturing the image. Since ...
Breaking Biology News(10 mins):
... January 14, 2013 Using an innovative approach, scientists ... structure of Ltn1, a recently discovered "quality-control" protein that ... and animals. Ltn1 appears to be essential ... also be relevant to human neurodegenerative diseases, for an ...
... 2013Taking a vitamin D supplement and drinking cow,s milk are ... D is in a child,s body, new research has found. ... colour and exposure to the sun, according to Dr. Jonathon ... "Early childhood is a critical stage in human development, so ...
... is Everywhere" tenet of bacterial distribution in the ocean, ... "bipolar" species of bacteria that occur in the Arctic ... they found even fewer bipolar species than would turn ... everywhere. "That suggests that there are forces that are ...
Cached Biology News: